BHV-8000, DaTSCAN 74 MBq/ml solution for injection, DaTSCAN 74 MBq/ml solution for injection, BHV-8000, Placebo for BHV-8000
BHV8000-301
Phase 3 small_molecule active
Quick answer
BHV-8000, DaTSCAN 74 MBq/ml solution for injection, DaTSCAN 74 MBq/ml solution for injection, BHV-8000, Placebo for BHV-8000 for Early Parkinson’s Disease is a Phase 3 program (small_molecule) at Biohaven Bioscience Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biohaven Bioscience Ireland Limited
- Indication
- Early Parkinson’s Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active